High prevalence of celiac disease among patients affected by Crohn's disease

Inflammatory Bowel Diseases

Volumn 11, Issue 7, 2005, Pages 662-666

  Tursi, Antonio ^a,d   Giorgetti, Gian Marco ^b   Brandimarte, Giovanni ^c   Elisei, Walter ^c  

^a Lorenzo Bonomo Hospital   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c Cristo Re Hospital   (Italy)

^d NONE   (Italy)

Author keywords

Antibodies; Celiac disease; Crohn's disease; Sorbitol H2 breath test

Indexed keywords

ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BREATH ANALYSIS; CELIAC DISEASE; CLINICAL ARTICLE; CROHN DISEASE; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOASSAY; INTESTINE BIOPSY; MALE; PRIORITY JOURNAL; SEROPREVALENCE;

ADOLESCENT; ADULT; AGED; BREATH TESTS; CELIAC DISEASE; CROHN DISEASE; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SORBITOL;

EID: 21844456679     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000164195.75207.1e     Document Type: Article

References (38)

1. Keighley MR, Stockbrugger RW. Inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18(suppl 3):66-70.
2. Martucci S, Biagi F, Di Sabatino A, et al. Coeliac disease. Dig Liver Dis. 2002;34(suppl 2):S150-S153.
3. Catassi C, Ratsch IM, Fabiani E, et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet. 1994;343:200-203.
4. Tursi A, Giorgetti GM, Brandimarte G, et al. Prevalence and clinical presentation of subclinical/silent coeliac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology. 2001;39: 462-464.
5. Cheikh I, Maamouri N, Chouaib S, et al. Association of celiac disease and Crohn's disease. A case report. Tunis Med. 2003;81:969-971.
6. Chakraborty A, Bremner AR, Moore I, et al. Coeliac disease and Crohn's disease: an association not to be forgotten. Hosp Med. 2003;64: 684-685.
7. Schedel J, Rockmann F, Bongartz T, et al. Association of Crohn's disease and latent celiac disease: a case report and review of the literature. Int J Colorectal Dis. 2004.
8. Kornbluth A, Salomon P, Sachard DB. Crohn's disease. In: Sleisenger MH, Fordtrand JS, eds. Gastrointestinal Disease. 5th ed. Philadelphia, PA: WB Saunders, 1993:1270-1304
9. Tursi A, Brandimarte G, Giorgetti GM, et al. Endoscopic features of coeliac disease in adults and its correlation with age, histological damage and clinical form of the disease. Endoscopy. 2002;34:787-792.
10. Feighery C, Weir DG, Whelan A, et al. Diagnosis of gluten-sensitive enteropathy: is exclusively reliance on histology appropriate? Eur J Gastroenterol Hepatol. 1998;10:919-925.
11. Oberhuber G, Grandisch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11:1185-1194.
12. Datele AVM, Aldhous MC, Humphreys K, et al. Serum tissue anti.transglutaminase antibodies in coeliac disease and other gastrointestinal disease. Q J Med. 2001;94:195-205.
13. Bizzarro N, Villalta D, Tonutti ER, et al. IgA and IgG tissue transglutaminase antibody prevalence and clinica significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis. Dig Dis Sci. 2003;48:2360-2365.
14. Sblattero D, Berti I, Trevisiol C, et al. Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. Am J Gastroenterol. 2000;95:1253-1257.
15. Tursi A, Brandimarte G, Giorgetti GM, et al. Low prevalence of anti-gliadin (AGA) and anti-endomysium (EMA) antibodies in subclinical/silent celiac disease. Am J Gastroenterol. 2001;96:1507-1510.
16. Abrams JA, Diamone B, Rotterdam H, et al. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci. 2004;49:546-550.
17. Corazza GR, Strocchi A, Rossi R, et al. Sorbitol malabsorption in normal volunteers and in patients with coeliac disease. Gut. 1988;29: 44-48.
18. 2-breath test in celiac disease. Importance of early positivity. Gastroenterol Int. 1998; 11:65-68.
19. 2-breath test versus anti-endomysium (EMA) antibodies for the diagnosis of subclinical/silent coeliac disese. Scand J Gastroenterol. 2001;36:1170-1172.
20. 2 breath tests for the diagnosis of celiac disease. Am J Gastroenterol. 2002;97:2679-2680.
21. Brocchi E, Tomassetti P, Misitano B, et al. Endoscopic markers in adult coeliac disease. Dig Liver Dis. 2002;34:177-182.
22. Culliford A, Markowitz D, Rotterdam H, et al. Scalloping of duodenal mucosa in Crohn's disease. Inflamm Bowel Dis. 2004;10:270-273.
23. Cottone M, Marrone C, Casa A, et al. Familial occurrence of inflammatory bowel disease in celiac disease. Inflamm Bowel Dis. 2003;9: 321-323.
24. Cominelli F. Cytokine-based therapies for Crohn's disease-new paradigms. N Engl J Med. 2004;351:2045-2048.
25. Levine AD, Fiocchi C. Regulation of life and death in lamina propria cells. Immunology. 2001;13:195-199.
26. Sturm A, Mohr S, Fiocchi C. Critical role of caspases in the regulation of apoptosis and proliferation of mucosal T cells. Gastroenterology. 2002;122:1334-1345.
27. Itoh J, De La Motte C, Strong SA, et al. Decreased BAX expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut. 2001;49:35-41.
28. Chermarsky AC, Rubio AF, Vanzulli S, Rubinstein N, De Rosa D, Fain boim L. Evidences of the involvement of Bak, a member of the Bcl-2 family proteins, in active coeliac disease. Autoimmunity. 2002;35:29-37.
29. Liu Z, Geboes K, Colpaert S, et al. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol. 2000;164:3608-3615.
30. Maiuri L, Ciacci C, Vacca L, et al. IL-15 drives the specific migration of CD94+ and TCR- gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol. 2001;96: 150-156.
31. Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signalling pathway converts CTL into lymphokine-activated K cells in celiac disease. Immunity. 2004;21: 357-366.
32. Jelinkova L, Tuckova L, Cinova J, et al. Gliadin stimulates human monocytes to production of IL-8 and TNF-alpha through a mechanism involving NF-kappaB. FEBS Lett. 2004;571:81-85.
33. Tursi A. The genetic puzzle of celiac disease. Gastroenterology. 2004;126:1216-1217.
34. Yap LM, Ahmad T, Jewell DP. The contribution of HLA genes to IBD susceptibility and phenotype. Best Pract Res Clin Gastroenterol. 2004;18:577-596.
35. Gibson PR. Increased gut permeability in Crohn's disease: is TNF the link? Gut. 2001;53:1724-1725.
36. Tursi A. Clinical implications of delayed orocecal transit time and bacterial overgrowth in adult patients with Crohn's disease. J Clin Gastroenterol. 2001;32:274-275.
37. Fasano A, Not T, Wang A, et al. Newly discovered modulator of intestinal permeability and its expression in celiac disease. Lancet. 2000;335: 1518-1519.
38. Barta Z, Csi Põ I, Szabó GG, et al. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol. 2003;9:2308-2312.